Thursday, May 8, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

940 POSTS 0 COMMENTS
Super Gonorrhea
All News

Antibiotic-Resistant Super Gonorrhea (CDC).

Editor / Curator -
All News

Is Overuse of Antibiotics on Farms Worsening the Spread of Antibiotic-Resistant...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Drug Resistance Could Kill 10M People per year by 2050, Experts...

Editor / Curator -
Superbug News - CoronaVirus Watch List

CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)

Editor / Curator -
CoronaVirus

‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus...

Editor / Curator -
American BriVision
Biotech News

American BriVision (ABVC) Improves Working Capital and Reduce Debt.

Editor / Curator -
All News

FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!

Editor / Curator -
Biotech News

Qiming Venture Partners Raises $1.1 Billion Fund VII

Editor / Curator -
Biotech Stock Review, Exsosomes
Biotech News

Exosomes, Extracellular Vesicles, and the CoronaVirus.

Editor / Curator -
Corbus Pharma, Biotech Stock Review
All News

Adding Corbis Pharma (CRBP) $5.55 to Watch List.

Editor / Curator -
1...697071...94Page 70 of 94

Latest article

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...

Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

All News Editor / Curator -
Gold prices broke $3,400 on Monday, hitting a new record as President Donald Trump’s threats against the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.